About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Horizon Therapeutics plc Among Top Companies for Overall Corporate Reputation in 2021 Global PatientView Survey of Patient Groups Worldwide

Horizon Ranked in Top Five for Patient Centricity, Patient-Group Relations and High Integrity

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked fifth in overall corporate reputation among patient groups that have worked directly with the company and seventh among patient groups who were familiar with the company. The results are based on PatientView’s annual survey of 2,150 patient groups.

For the 2021 survey, 180 patient groups claimed familiarity with Horizon, an increase of 46 from 2020. Additionally, 87 groups said they had worked with the company, an increase of 51 from 2020.

“At Horizon, being an advocate is personal because many employees are patients or caregivers,” said Matt Flesch, vice president, patient advocacy and communications. “In 2021 we were energized by meeting and supporting many new patient advocacy groups as Horizon expanded internationally and began working on several new disease states to support our growing pipeline. We are grateful for the feedback we’ve received as part of the PatientView survey and strive to continue to actively engage new patient groups and support their efforts.”

Report Highlights

The survey results were reported in two sets of rankings: one based on responses from groups that have worked directly with the company, the other from groups that are familiar with Horizon, but have not worked with the company.

  • For both rankings, in each of the 13 indicators, Horizon ranked in the top tier of global pharmaceutical and biotechnology companies.
  • Among patient groups that reported partnering with Horizon, the company ranked fifth overall; these groups ranked the company in the top five when asked about attributes such as patient centricity, patient-group relations and high integrity.
  • Among patient groups who had not worked with the company, Horizon ranked seventh overall in familiarity.

Horizon’s Commitment to Patients and their Advocates

Horizon actively partners with patient advocacy organizations to raise awareness for many underrepresented diseases and to advocate on behalf of patients and their communities. 2021 highlights included:

  • Partnered with EveryLife Foundation to provide enrichment for patients through the #RAREis Scholarship, a $1 million commitment through 2025 to support the pursuit of life enrichment activities for adults (17+) living with rare diseases for a variety of educational pursuits, including educational courses and obtaining two-and four-year degrees. To date, nearly 100 adults living with rare diseases have received $5,000 educational scholarships. Applications for Fall 2023 will open in Spring 2023.
  • Amplified voices and supported sharing uncensored truths about rare disease through the #RAREis program. Since inception in 2017 more than 300 photos, blogs and stories submitted by the rare disease community, covering more than 70 different rare diseases have been featured on the platform. Horizon also has featured more than 30 #RAREis Voices videos from leading advocates, patients and researchers sharing common experiences many living with rare diseases face.
  • Partnered with the Jeffrey Modell Diagnostic and Research Center to support the expansion of two of their centers. The multi-pronged initiative aims to remove diagnostic barriers and increase awareness programs for people impacted by Primary Immunodeficiency.
  • Collaborated with more than 100 patient groups to expand outreach, increase engagement and develop educational opportunities for patients and their caregivers in live and virtual settings to elevate their stories, experiences and voices.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.